Skip to main content

Myositis Ossificans

  • Living reference work entry
  • First Online:
  • 47 Accesses

Part of the book series: Encyclopedia of Pathology ((EP))

Synonyms

Myositis ossificans circumscripta; Pseudomalignant osseous tumors of soft tissues

Definition

Myositis ossificans (MO) is a benign self-limiting, pseudosarcomatous ossifying lesion that in most cases is secondary to an obvious trauma or minor repetitive trauma.

Clinical Features

  • Age

    It occurs over a broad age range, with a peak in the second and third decades of life (Ackerman 1958; Nuovo et al. 1992; de Silva and Reid 2003).

  • Sex

    There is a predilection for male subjects.

  • Site

    MO can develop at any site, but it occurs more commonly in the skeletal muscles of the lower extremities, especially the thighs and buttocks. Lesions similar to MO can develop in the subcutaneous fat (panniculitis ossificans), in the mesentery (heterotopic mesenteric ossification), in the fascia (fasciitis ossificans), or in the fingers (fibro-osseous pseudotumor of the digits).

  • Treatment

    Once the diagnosis has been reached, surgical treatment is not strictly necessary, unless the lesion causes...

This is a preview of subscription content, log in via an institution.

References and Further Reading

  • Ackerman, L. V. (1958). Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans): Clinical and pathological confusion with malignant neoplasms. The Journal of Bone and Joint Surgery. American Volume, 40-A, 279–298.

    Article  CAS  Google Scholar 

  • Bekers, E. M., Eijkelenboom, A., Grünberg, K., Roverts, R. C., de Rooy, J. W. J., van der Geest, I. C. M., van Gorp, J. M., Creytens, D., & Flucke, U. (2018). Myositis ossificans – Another condition with USP6 rearrangement, providing evidence of a relationship with nodular fasciitis and aneurysmal bone cyst. Annals of Diagnostic Pathology, 34, 56–59.

    Article  Google Scholar 

  • de Silva, M. V., & Reid, R. (2003). Myositis ossificans and fibroosseous pseudotumor of digits: A clinicopathological review of 64 cases with emphasis on diagnostic pitfalls. International Journal of Surgical Pathology, 11, 187–195.

    Article  Google Scholar 

  • Flucke, U., Bekers, E. M., Creytens, D., & van Gorp, J. M. (2018). COL1A1 is a fusion partner of USP6 in myositis ossificans – FISH analysis of six cases. Annals of Diagnostic Pathology, 36, 61–62.

    Article  Google Scholar 

  • McCarthy, E. F., & Sundaram, M. (2005). Heterotopic ossification: A review. Skeletal Radiology, 34, 609–619.

    Article  CAS  Google Scholar 

  • Nuovo, M. A., Norman, A., Chumas, J., & Ackerman, L. V. (1992). Myositis ossificans with atypical clinical, radiographic, or pathologic findings: A review of 23 cases. Skeletal Radiology, 21, 87–101.

    Article  CAS  Google Scholar 

  • Švajdler, M., Michal, M., Martínek, P., Ptáková, N., Kinkor, Z., Szépe, P., Švajdler, P., Mezencev, R., & Michal, M. (2019). Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: A clinicopathological and genetic study of 27 cases. Human Pathology, 88, 39–47.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessandro Franchi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Franchi, A. (2020). Myositis Ossificans. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5436-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_5436-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics